- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT06364137
Envolvimento e impacto clínico da plataforma de terapia virtual Teleo em ambientes clínicos - Pilot RCT
The research study will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the pilot trial will examine examine patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
The research study will examine engagement in telehealth for children undergoing psychotherapy. The study in Phase I entails a pilot randomized trial with a goal to enroll children from 42 families and their therapists, examining patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.
Engagement will be assessed using well-established measures - CIRS (modified) video coding (session 1), MTT-Y/MTTCG (sessions 1, 4) and attendance data (sessions 1-4). Clinicians in the study will deliver therapy to clients for 4 sessions, providing opportunity to measure temporal sustainment of any engagement differences.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
California
-
Stanford, California, Estados Unidos, 94305
- Stanford University
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Receiving psychotherapy with a licensed professional on the Teleo platform
- Likely have at least 12 sessions remaining.
- Diagnosis of a mental health condition by a licensed clinician
Exclusion Criteria:
- Not under treatment with provider using Teleo platform
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Pesquisa de serviços de saúde
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Teleo
Participants in this group will undergo therapy for 4 sessions using the Teleo virtual therapy video platform, sessions will be recorded and questionnaires and clinical data will be measured. |
Therapist-led psychotherapy sessions implemented within the Teleo virtual therapy platform. |
|
Comparador Ativo: Standard videoconferencing
Participants in this group will undergo therapy for 4 sessions using standard video platforms (e.g. zoom or other publicly available product), sessions will be recorded and questionnaires and clinical data will be measured. |
Therapist-led psychotherapy sessions implemented in standard (non-Teleo) video platform |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Child Involvement Rating Scale (CIRS)
Prazo: Week 1
|
The Child Involvement Rating Scale (CIRS) is a 10-item observer-rated measure of child engagement in therapy. Each item is rated on a 6-point Likert scale ranging from 0 (No presence) to 5 (A great deal). Six items (initiating discussion, suggesting task changes, enthusiastic participation, self-disclosure, asking questions, and elaboration) assess positive therapeutic engagement, where a higher score indicates greater engagement. The four remaining items (withdrawal, avoidance, distraction, and oppositionality) assess disengagement-related behaviors, where a higher score indicates greater disengagement. The six engagement items are directly scored (a rating of 0 is scored as 0, and a rating of 5 is scored as 5). The four disengagement items are reverse-scored (a rating of 0 is scored as 5, and a rating of 5 is scored as 0). All 10 item scores are summed to produce a CIRS total score ranging from 0 to 50. Higher total scores indicate greater child engagement (better outcomes). |
Week 1
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
My Thoughts About Therapy - Caregiver (MTT-CG)
Prazo: Weeks 1 and 4
|
The My Thoughts About Therapy Questionnaire - Caregiver Version (MTT-CG) is a 35-item questionnaire with 5 subscales, each with 7 items, that represent the multidimensional REACH framework for characterizing treatment engagement: Relationship, Expectancy, Attendance, Clarity, and Homework (Becker et al., 2018). Items are rated on a 4-point Likert-scale from 0 ("strongly disagree") to 3 ("strongly agree"). To score the MTT, each item is assigned a numerical value from 0-3, where 0 = strongly disagree, 1 = disagree, 2 = agree, and 3 = strongly agree. For each subscale add the numerical values for each of the 7 items together. Thus, the highest subscale score possible is 21, the lowest 0. The total score is calculated as the sum of the 5 subscale scores, with a maximum possible score of 105 and a minimum possible score of 0. |
Weeks 1 and 4
|
|
My Thoughts About Therapy - Youth Version (MTT-Y)
Prazo: Weeks 1 and 4
|
The My Thoughts About Therapy Questionnaire - Youth Version (MTT-Y) is a 35-item questionnaire with 5 subscales, each with 7 items, that represent the multidimensional REACH framework for characterizing treatment engagement: Relationship, Expectancy, Attendance, Clarity, and Homework (Becker et al., 2018). Items are rated on a 4-point Likert-scale from 0 ("strongly disagree") to 3 ("strongly agree"). To score the MTT, each item is assigned a numerical value from 0-3, where 0 = strongly disagree, 1 = disagree, 2 = agree, and 3 = strongly agree. For each subscale add the numerical values for each of the 7 items together. Thus, the highest subscale score possible is 21, the lowest 0. The total score is calculated as the sum of the 5 subscale scores, with a maximum possible score of 105 and a minimum possible score of 0. |
Weeks 1 and 4
|
|
Psychotherapy Session Attendance
Prazo: Weeks 1-4
|
Clinicians recorded attendance for each of the 4 scheduled therapy sessions (Weeks 1-4) on an attendance form, categorizing each session as attended on time, attended late (10+ minutes), rescheduled/cancelled, no-show, or treatment dropout. The reported value is the number of sessions attended on time in each arm, calculated as a single pooled proportion across participants: the number of sessions attended on time divided by the number of scheduled sessions for all participants in that arm. Values range from 0 to 1, with higher values indicating better attendance. |
Weeks 1-4
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: David S Hong, MD, Stanford University
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 73203
- R42MH136878 (Concessão/Contrato do NIH dos EUA)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .